Schedule 13D ownership disclosure

REVIVA PHARMACEUTCLS HLDGS I

Security class unavailable · CUSIP: 76152G100

Event date: 2021-06-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-080321
Form type
SC 13D/A
Filer
Nayar Rahul
CIK
CIK 1744923
Filed
Jun 14, 2021
Reporting period
Jun 01, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub